tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Avadel Pharmaceuticals Elects New Board and Auditor

Story Highlights
Avadel Pharmaceuticals Elects New Board and Auditor

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Avadel Pharmaceuticals ( (AVDL) ) has issued an announcement.

On July 29, 2025, Avadel Pharmaceuticals held its Annual Meeting of Shareholders where a quorum was established with 83,659,463 shares represented. The meeting resulted in the election of seven directors to the Board for a one-year term and the ratification of Deloitte & Touche LLP as the company’s independent auditor for the fiscal year ending December 31, 2025. These decisions are expected to impact the company’s governance and financial oversight positively.

The most recent analyst rating on (AVDL) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Avadel Pharmaceuticals stock, see the AVDL Stock Forecast page.

Spark’s Take on AVDL Stock

According to Spark, TipRanks’ AI Analyst, AVDL is a Neutral.

Avadel Pharmaceuticals’ overall stock score reflects robust growth potential driven by strong product adoption and strategic corporate developments. However, ongoing profitability challenges and valuation concerns limit the upside. Technical momentum provides a positive outlook, but investors should be cautious of overbought signals.

To see Spark’s full report on AVDL stock, click here.

More about Avadel Pharmaceuticals

Avadel Pharmaceuticals plc operates in the pharmaceutical industry, focusing on developing and commercializing innovative medicines. The company is known for its efforts in addressing unmet medical needs, particularly in the realm of sleep disorders and other therapeutic areas.

Average Trading Volume: 1,387,823

Technical Sentiment Signal: Buy

Current Market Cap: $1.05B

For a thorough assessment of AVDL stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1